Twenty noncanonical cytochrome P450 families lacking a conserved cysteine ligand are identified in diverse microbial genomes, including the first native selenocysteine-ligated CYP.
Pharmacogenetics and Drug Metabolism
Moving in bioRxiv, Nature Chemical Biology, Applied and environmental microbiology, Biotechnology advances, Communications Biology, Environmental pollution, Nature Reviews Drug Discovery and The Lancet Oncology.
- Moved, week to 22 Oct 2026
- 0
- Papers in 60 days
- 10
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Pharmacogenetics and Drug Metabolism
Newest first · last 60 days
Enhancing P450 enzyme components with greater degrees of freedom is key to expanding biocatalytic opportunities in pharmaceutical applications.
- Open access
Simulation-guided design enhances complex clinical trial planning by evaluating operating characteristics and refining protocols for accelerated drug development.
A high-resolution GWAS of nearly 600,000 East Asians identified 196 loci for T2D, including three novel loci, with 74% shared causal signals across populations.
- Open access
Browse JClub
Journals this month
- bioRxiv6054
- medRxiv1746
- PNAS447
- Sci Adv354
- JAMA268
- Environ Res246
- BMJ196
- Nat Commun173
- Environ Pollution167
- Nature151
- Science141
- Lancet128
- Cell Rep127
- NEJM118
- Plant Cell Environ114
- Applied & Environ Microbio112
- Curr Biol106
- Blood105
Topics moving, week to 22 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Cancer Immunotherapy and Biomarkers5
- Gut microbiota and health5
- Cancer Genomics and Diagnostics4
- Bacteriophages and microbial interactions4
- CAR-T cell therapy research3
- Lung Cancer Treatments and Mutations3
- Liver Disease Diagnosis and Treatment3
- Dementia and Cognitive Impairment Research3
